News

News


5 May 2011
Dr. Peter Andersen, the Vice President of Vaccine Research and Development at Statens Serum Institut (SSI) and TBVI partner, has been awarded the prestigious Novo Nordisk prize for his work in TB vaccine development. The WGND interviewed Dr. Andersen for our TB R&D Weekly Update on March 8...
3 May 2011
The first detailed study of the private tuberculosis (TB) drug market, published on May 4 th , in the PLoS ONE journal, finds that the market is surprisingly large, and has irregular practices that could be driving treatment failures and contributing to the emergence of multidrug-resistant TB (MDR-...
2 May 2011
Photos of Lalita Ramakrishnan, Paul Edelstein, and Christine Cosma Summary: The WGND had the opportunity to interview three researchers (Lalita Ramakrishnan, Paul Edelstein, and Christine Cosma) involved in the groundbreaking research on the role of efflux pumps in contributing to drug tolerance...
28 Apr 2011
The Stop TB Partnership and the World Health Organization are announcing a call for applications for members to serve on the Global GLC . Deadline for submission of applications is 16 May 2011. A Global GLC Committee (the “gGLC”) is being established that will be 1) a sub-group of the MDR-TB...
27 Apr 2011
Dr. Mark Cotton is Director of Children’s Infectious Diseases Clinical Research Unit (KID-CRU) at University of Stellenbosch in Cape Town, South Africa. Pediatric TB has emerged as a broad priority only in more recent years, though the University of Stellenbosch / Tygerberg Hospital team has been...
25 Apr 2011
Paul Elkington, Takayuki Shiomi, Ronan Breen, Robert K. Nuttall, Cesar Augusto Ugarte-Gil, Naomi F. Walker, Luísa Saraiva, Bernadette Pedersen, Francesco Mauri, Marc Lipman, Dylan R. Edwards, Brian D. Robertson, Jeanine D’Armiento and Jon S. Friedland. MMP-1 drives immunopathology in human...
20 Apr 2011
Stop TB Partnership This is the April 2011 edition of Stop TB News, which is distributed by email by the Stop TB Partnership . TOP LINE NEWS African health ministers take Washington by storm The health ministers of Lesotho, South Africa and Swaziland joined the Stop TB Partnership in Washington DC...
18 Apr 2011
Lienhardt C, Cook SV, Burgos M, Yorke-Edwards V, Rigouts L, Anyo G, Kim SJ, Jindani A, Enarson DA, Nunn AJ; Study C Trial Group. Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: the Study C randomized controlled...
13 Apr 2011
If you are having trouble viewing, click here . CORE Group Online Presentation about New TB Diagnostic Technology, Xpert®MTB/RI How does it work? Where can it be used? How might it make a difference in the global effort to stop TB? Hosted online by the CORE Group Tuberculosis Working Group on March...
11 Apr 2011
Monedero I, Caminero JA. Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review. Int J Tuberc Lung Dis. 2011 Apr;15(4):433-9. In this week’s article, Monedero and Caminero conduct a critical review of research on the use of fixed-dosed combinations (FDCs...
6 Apr 2011
Photo by John-Michael Maas Each day, thousands of people around the world are affected by tuberculosis whether directly or indirectly, and every 20 seconds one of these people die. TB hits all ages and all races with great devastation, but has become so ingrained in history that it has been assumed...
4 Apr 2011
Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax. 2011 Apr 2. [Epub ahead of print] This week, the focus is on...
30 Mar 2011
Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS). Having the...
28 Mar 2011
The New York Academy of Sciences will be hosting a symposium entitled “New Frontiers in Marine Drug Discovery” on May 20, 2011. This 1-day symposium will overview the current state of the art in Marine Biomedicine and its role in the context of the drug discovery process – from the perspectives of...
24 Mar 2011
The following is an e-mail circulated on the Stop TB Advocacy Network from a TB patient named Pervaiz Tufail, location unknown. It is a powerful message from the patient’s perspective. Subject: TODAY IS WORD TB DAY BUT WHERE AM I? I heard Akram died of TB today, last week Rizwan died and I am...

Pages